Medicine that impairs driving also commonly causes sedation, motor coordination, hypoglycemia, blurred vision, hypotension, syncope, and ataxia. The antidepressants that cause these ill effects are benzodiazepines, sedatives and hypnotics, antihistamines, opioids, antipsychotics, and anticholinergics.
Previous systematic meta-analyses with older adult samples found that driving impairment was identified for specific medical conditions, such as dementia, Parkinson disease, and stroke. People who reported being Black also have a higher risk of driving impairment, mobility restriction, and driving cessation compared to people who reported being White.
Carr and colleagues wanted to determine whether certain classes of medication increase risk of driving impairment.
In the study, people who received a marginal/fail rating on the road test had a lower near visual acuity scores, with the mean score 63.8 at baseline (P = .001).
“This cohort study found that in a cognitively healthy, community-residing sample of adults 65 years and older who were taking SSRI or SNRIs, antidepressants, sedatives or hypnotics, or NSAIDs or acetaminophen were found to have a higher risk of driving impairment on a road test (marginal/fail rating) compared to nonuse,” investigators wrote. “These results suggest that the potentially driver-impairing medication classes may increase the risk or poor driving performance over time among older drivers.”
Nonsteroidal anti-inflammatory (NSAID) drugs typically do not impact driving if taken correctly, but they can result in adverse effects, such as dizziness, lightheadedness, drowsiness, vision impairment, and difficulty concentrating.
“Long-term use of NSAIDs by older patients is common and could result in drug-drug interactions that exacerbate existing medical conditions known to contribute to driving impairment, such as hypertension and heart failure,” investigators concluded.
References
Carr DB, Beyene K, Doherty J, et al. Medication and Road Test Performance Among Cognitively Healthy Older Adults. JAMA Netw Open. 2023;6(9):e2335651. doi:10.1001/jamanetworkopen.2023.35651